Intra-abdominal Infections
📧 Sign up to get email alerts when something new happens for Intra-abdominal Infections.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-08-18FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Metronidazole from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
FDA approval · 2021-03-16FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for Piperacillin and Tazobactam (piperacillin sodium and tazobactam sodium) submitted by Eugia U…
-
FDA label_change · 2020-05-26FDA Approved: ZOSYN IN GALAXY CONTAINERS — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for ZOSYN in Galaxy containers, a packaging/labeling change for the piperacillin/tazobactam product.…
-
FDA approval · 2019-08-20FDA Approved: CLINDAMYCIN HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for clindamycin hydrochloride from Chartwell RX, LLC.
-
FDA approval · 2019-08-14FDA Approved: METRONIDAZOLE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for Metronidazole from Unichem Pharmaceuticals (USA), Inc., supporting a generic version under A…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-06-12FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the vancomycin hydrochloride original application for Slate Run Pharmaceuticals, enabling a generic version of this antibiotic.
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004) [Phase 2]
Phase 2 trial evaluating relebactam with imipenem/cilastatin versus imipenem/cilastatin alone for complicated intra-abdominal infection has …
-
FDA approval · 2018-08-10FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Shandong Anxin Pharmaceutical Co., Ltd.)
FDA approved the original application for a generic Piperacillin and Tazobactam combination from Shandong Anxin Pharmaceutical Co., Ltd., ex…
-
FDA approval · 2018-05-18FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Fresenius Kabi USA, LLC)
FDA approves Fresenius Kabi USA, LLC's original generic application for Piperacillin and tazobactam (Piperacillin and tazobactam), authorizi…
-
FDA approval · 2017-09-05FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for METRONIDAZOLE from Aurobindo Pharma Limited (ANDA 203974).
-
CLINICAL_TRIALS research · 2017-06-29Clinical Trial Update: Abdominal SepsiS Study: Epidemiology of Etiology and Outcome
The Abdominal SepsiS study on the epidemiology of etiology and outcomes in intra-abdominal infections has completed.
-
FDA approval · 2016-05-12FDA Approved: CLINDAMYCIN PHOSPHATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved the supplemental application for clindamycin phosphate (Padagis Israel Pharmaceuticals Ltd), reflecting approval of the supplem…
-
FDA approval · 2016-01-21FDA Approved: CLEOCIN HYDROCHLORIDE — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for CLEOCIN HYDROCHLORIDE (clindamycin hydrochloride) filed by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2015-12-07FDA Approved: AMPICILLIN AND SULBACTAM — Original Application (WG Critical Care, LLC)
FDA approved Ampicillin and Sulbactam from WG Critical Care, LLC under an Original Application (ANDA), making a generic antibiotic available…
-
FDA label_change · 2014-09-22FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
The FDA approved a supplemental application for amoxicillin and clavulanate potassium filed by Northstar RxLLC, resulting in a label update …
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection [Phase 3]
Pfizer-sponsored Phase 3 study of intravenous metronidazole for intra-abdominal infections has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Post-Authorization Study Evaluating Safety Of Tigecycline
Pfizer completed a post-authorization safety study evaluating tigecycline, with results posted in February 2012. The safety data cover patie…
-
FDA approval · 2012-01-20FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of amoxicillin and clavulanate potassium from Aurobindo Pharma Limited under an Original Application (ANDA 09…
-
FDA approval · 2011-09-30FDA Approved: CLINDAMYCIN — Original Application (Sagent Pharmaceuticals)
FDA approved Sagent Pharmaceuticals' original application for CLINDAMYCIN PHOSPHATE (clindamycin), a generic antibiotic for treating suscept…
-
FDA approval · 2010-09-20FDA Approved: AMPICILLIN AND SULBACTAM — Original Application (Eugia US LLC)
FDA approved an original ANDA for Ampicillin and Sulbactam by Eugia US LLC, authorizing a generic version of the ampicillin-sulbactam antibi…
-
FDA approval · 2010-05-05FDA Approved: METRONIDAZOLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original application for Metronidazole from Alembic Pharmaceuticals Limited (generic approval).
-
FDA approval · 2009-03-13FDA Approved: METRONIDAZOLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original ANDA from Alembic Pharmaceuticals Limited for a generic metronidazole product.
-
FDA approval · 2009-03-05FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Amoxicillin and Clavulanate Potassium, a generic antibiotic (…
-
FDA approval · 2007-10-25FDA Approved: METRONIDAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for metronidazole (ANDA070027), authorizing changes to the approved product through a supplemen…
-
FDA approval · 2007-08-13FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's amoxicillin/clavulanate potassium as an Original Application (ANDA), granting approval for a generic antibiotic pr…